Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Autor: Wiseman, Gregory A *, White, Christine A, Sparks, Richard B, Erwin, William D, Podoloff, Donald A, Lamonica, Dominick, Bartlett, Nancy L, Anthony Parker, J, Dunn, William L, Spies, Stewart M, Belanger, Richard, Witzig, Thomas E, Leigh, Bryan R
Zdroj: In Critical Reviews in Oncology and Hematology 2001 39(1):181-194
Databáze: ScienceDirect